GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) announces it has renewed its at-the-market equity program (the "ATM Program") that allows the Company to distribute up ...

Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) has entered into an equity distribution agreement (the “Distribution Agreement”) with TD Securities (USA) LLC (the ...

Any Common Shares sold under the ATM Program will be sold at market price, or as otherwise agreed upon by the Company and Roth by means of ordinary brokers' transactions on the Nasdaq Capital Market ( ...

Sprott Asset Management announces updated equity program to issue up to $250 million in Trust units for gold and silver investments. Sprott Asset Management LP announced an update to its at-the-market ...

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PMCET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the “Company”), ...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- Lithium Americas Corp. (LAC:CA) (“Lithium Americas” or the “Company”) has entered into an equity distribution agreement (the “Distribution Agreement”) ...

At-the-market (ATM) offering programs continue to provide public real estate investment trusts (REITs) and other issuers an efficient means of raising capital over time by allowing a listed company to ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 28, 2025, to its short form base shelf prospectus dated March 6, 2025.

On May 28, 2024, the standard settlement cycle for most broker-dealer transactions was shortened from a two business day settlement period (T+2) to one business day (T+1). Under the T+1 settlement ...

During the term of the ATM program, the Company will include in the publication of its financial results information about its use of the program during the preceding quarter and will also provide an ...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics TM ”, announced ...